492 related articles for article (PubMed ID: 24434314)
1. Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells.
Singh B; Schwartz JA; Sandrock C; Bellemore SM; Nikoopour E
Indian J Med Res; 2013 Nov; 138(5):591-4. PubMed ID: 24434314
[TBL] [Abstract][Full Text] [Related]
2. Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg 17) cells in type 1 diabetes in non-obese diabetic mice.
Bellemore SM; Nikoopour E; Schwartz JA; Krougly O; Lee-Chan E; Singh B
Clin Exp Immunol; 2015 Dec; 182(3):261-9. PubMed ID: 26250153
[TBL] [Abstract][Full Text] [Related]
3. Bacillus-derived poly-γ-glutamic acid reciprocally regulates the differentiation of T helper 17 and regulatory T cells and attenuates experimental autoimmune encephalomyelitis.
Lee K; Hwang S; Paik DJ; Kim WK; Kim JM; Youn J
Clin Exp Immunol; 2012 Oct; 170(1):66-76. PubMed ID: 22943202
[TBL] [Abstract][Full Text] [Related]
4. IL-17 and Th17 Cells.
Korn T; Bettelli E; Oukka M; Kuchroo VK
Annu Rev Immunol; 2009; 27():485-517. PubMed ID: 19132915
[TBL] [Abstract][Full Text] [Related]
5. PPARα suppresses Th17 cell differentiation through IL-6/STAT3/RORγt pathway in experimental autoimmune myocarditis.
Chang H; Zhao F; Xie X; Liao Y; Song Y; Liu C; Wu Y; Wang Y; Liu D; Wang Y; Zou J; Qi Z
Exp Cell Res; 2019 Feb; 375(1):22-30. PubMed ID: 30557558
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
7. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
8. Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-beta-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression.
Xiao S; Jin H; Korn T; Liu SM; Oukka M; Lim B; Kuchroo VK
J Immunol; 2008 Aug; 181(4):2277-84. PubMed ID: 18684916
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic potential of TGF-β-induced CD4(+) Foxp3(+) regulatory T cells in autoimmune diseases.
Zhou X; Kong N; Zou H; Brand D; Li X; Liu Z; Zheng SG
Autoimmunity; 2011 Feb; 44(1):43-50. PubMed ID: 20670119
[TBL] [Abstract][Full Text] [Related]
10. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.
Afzali B; Lombardi G; Lechler RI; Lord GM
Clin Exp Immunol; 2007 Apr; 148(1):32-46. PubMed ID: 17328715
[TBL] [Abstract][Full Text] [Related]
11. New complexities in helper T cell fate determination and the implications for autoimmune diseases.
Takatori H; Kanno Y; Chen Z; O'Shea JJ
Mod Rheumatol; 2008; 18(6):533-41. PubMed ID: 18679768
[TBL] [Abstract][Full Text] [Related]
12. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells.
Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR
Cell; 2006 Sep; 126(6):1121-33. PubMed ID: 16990136
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of IL-27 Signaling Exacerbates Experimental Autoimmune Uveitis with Elevated Uveitogenic Th1 and Th17 Responses.
Wu S; Ma R; Zhong Y; Chen Z; Zhou H; Zhou M; Chong W; Chen J
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299138
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells regulate experimental autoimmune uveitis through inhibition of Th17 differentiation.
Oh K; Byoun OJ; Ham DI; Kim YS; Lee DS
Eur J Immunol; 2011 Feb; 41(2):392-402. PubMed ID: 21268009
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
[TBL] [Abstract][Full Text] [Related]
16. IL-6: regulator of Treg/Th17 balance.
Kimura A; Kishimoto T
Eur J Immunol; 2010 Jul; 40(7):1830-5. PubMed ID: 20583029
[TBL] [Abstract][Full Text] [Related]
17. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
Yamagata T; Skepner J; Yang J
Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
[TBL] [Abstract][Full Text] [Related]
18. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
19. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
[TBL] [Abstract][Full Text] [Related]
20. A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.
Stadhouders R; Lubberts E; Hendriks RW
J Autoimmun; 2018 Feb; 87():1-15. PubMed ID: 29275836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
